Stock research

Morgan Stanley (MS) Stock Research

Morgan Stanley pairs an investment bank with a large wealth-management platform built through major acquisitions.

For the fiscal year ended December 31, 2025, Morgan Stanley reported revenue of $70.6B and net income of $16.9B, with operating cash flow of −$17.9B. Source: Form 10-K filed February 19, 2026

SEC data as of

Revenue
$70.6B
FY ending 2025-12-31
Net income
$16.9B
FY ending 2025-12-31
Diluted EPS
$10.21
Net margin
23.9%

Reported SEC XBRL figures. Each metric’s period and original filing are listed below.

Loading delayed market data…

Delayed Cboe One market data via TradingView. It may differ from primary-exchange or consolidated quotes.

About Morgan Stanley

The wealth business provides steadier fee income to offset volatile trading results.

Exchange
NYSE: MS
Sector
Financials
SEC industry
Security Brokers, Dealers & Flotation Companies (SIC 6211)
Fiscal year end
December 31
Headquarters
New York, New York
Founded
1935

MS key financials

Reported figures from Morgan Stanley's filings, pulled directly from SEC XBRL data rather than a third-party terminal. Each row links to the filing it came from.

MetricValuePeriodSource
Revenue$70.6B2025-01-01 – 2025-12-31SEC filing
Net income$16.9B2025-01-01 – 2025-12-31SEC filing
Operating cash flow−$17.9B2025-01-01 – 2025-12-31SEC filing
Diluted EPS$10.212025-01-01 – 2025-12-31SEC filing
Net margin23.9%2025-01-01 – 2025-12-31SEC filing
Shares outstanding1.59BAs of 2026-01-31SEC filing

Values are as tagged by the issuer in XBRL. Revenue for banks and insurers is net of interest expense where that is the reported line. Fiscal years that do not follow the calendar are shown by their period-end date. No price, market cap, or valuation multiple is shown because Yield Theory does not republish unlicensed market data.

Diluted EPS is the earnings figure behind the price-to-earnings ratio; the P/E multiple compression calculator shows how a change in that multiple moves a share price. Shares outstanding multiplied by the share price gives market capitalization.

What investors should watch in MS

Morgan Stanley sits in Financials. Banks, insurers, asset managers, and exchanges — the plumbing of capital markets, geared directly to interest rates and credit. We have not yet written company-specific drivers for MS; the forces that matter most for the sector are:

  • ◆The shape of the yield curve and net interest margins
  • ◆Credit quality and loan-loss provisions
  • ◆Regulation and capital requirements
  • ◆Deal activity and market volatility

Key questions for the MS thesis

Each question starts with what the filings show, then why it matters. None of these is a rating or a forecast.

Does MS's reported profit turn into cash?

Operating cash flow was −$17.9B, -1.06 times net income of $16.9B, for the fiscal year ended December 31, 2025.

Cash from operations trailed reported earnings. Working-capital build (receivables, inventory, prepayments) or non-cash gains are the usual reasons; check the cash-flow statement before relying on reported profit.

Form 10-K filed February 19, 2026

How much of MS's revenue is left as profit?

Net income was 23.9% of revenue for the fiscal year ended December 31, 2025, based on revenue and net income reported for the same period.

Net margin reflects the business model as much as execution, so compare it with companies in the same SEC industry and read the income statement for one-time items before treating it as a run rate.

Form 10-K filed February 19, 2026

Members-only research

What members are reading this month

The thesis, the numbers behind it, and what would break it. Full access is $39 a month.

Read the full research

Congressional trading in MS

PoliticianTrade dateTypeOwnerAmountSource
Dan Newhouse2026-07-10PurchaseSpouse$1,001 - $15,000Filing #20034998
Alan Armstrong2026-03-27PurchaseSelf$1,001 - $15,000Filing #fda235b3-bad7-4637-8fa1-053f354d929c
Julie Johnson2025-12-18SaleJoint$1,001 - $15,000Filing #20033789
Steve Cohen2025-12-17SaleSelf$50,001 - $100,000Filing #20033754
Gilbert Cisneros2025-11-18PurchaseSelf$1,001 - $15,000Filing #20033619
Julie Johnson2025-11-13SaleJoint$1,001 - $15,000Filing #20033611
Gilbert Cisneros2025-10-17PurchaseSelf$1,001 - $15,000Filing #20033455
Valerie Hoyle2025-09-23SaleSpouse$1,001 - $15,000Filing #20032211
Marjorie Greene2025-09-11PurchaseSelf$1,001 - $15,000Filing #20032174
Marjorie Greene2025-08-28PurchaseSelf$1,001 - $15,000Filing #20030996

All verified MS congressional disclosures

Congressional disclosures are delayed, range-based records—not real-time signals or proof of motive. See the source-linked tracker for scope and limitations.

MS — frequently asked questions

What does Morgan Stanley do?

Morgan Stanley pairs an investment bank with a large wealth-management platform built through major acquisitions.

What were MS's latest reported annual revenue and net income?

For the fiscal year ended December 31, 2025, Morgan Stanley reported revenue of $70.6B and net income of $16.9B, with operating cash flow of −$17.9B. The figures come from Morgan Stanley's SEC XBRL filings.

When does Morgan Stanley's fiscal year end?

The SEC lists Morgan Stanley's fiscal year end as December 31.

Do members of Congress trade MS?

The current verified House and Senate snapshot contains 23 transaction rows for MS, each linked to the original filing.

Where is Morgan Stanley headquartered?

Morgan Stanley is headquartered in New York, New York and was founded in 1935.

Is MS a good investment?

This page does not rate MS as a buy or sell. It sets out what Morgan Stanley reports, what investors should watch and the questions a thesis has to answer, with links to the SEC filings. It is research, not investment advice.

This page is independent research and educational information, not investment advice or a recommendation to buy or sell any security. Company facts are compiled from public sources. Do your own research.

What do the MS numbers leave unanswered?

Financials describe the business. The next question is which assumptions an investment thesis depends on. Explore the member reports below for analysis of catalysts, risks, and what would change the view. $39/month or $249/year.

$39/mo or $249/yr · cancel future renewals anytime · sources included